136 related articles for article (PubMed ID: 28803745)
1. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of medication-related osteonecrosis of the jaw: a comparative study of in vivo and in vitro trials.
Holtmann H; Lommen J; Kübler NR; Sproll C; Rana M; Karschuck P; Depprich R
J Int Med Res; 2018 Oct; 46(10):4277-4296. PubMed ID: 30091399
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional clinical assessment for MRONJ risk in oncologic patients following tooth extractions.
Moreno Rabie C; Cavalcante Fontenele R; Oliveira Santos N; Nogueira Reis F; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230238. PubMed ID: 37874081
[TBL] [Abstract][Full Text] [Related]
4. Rodents as an animal model for studying tooth extraction-related medication-related osteonecrosis of the jaw: assessment of outcomes.
Hadad H; Matheus HR; Pai SI; Souza FA; Guastaldi FPS
Arch Oral Biol; 2024 Mar; 159():105875. PubMed ID: 38160519
[TBL] [Abstract][Full Text] [Related]
5. Local radiographic risk factors for MRONJ in osteoporotic patients undergoing tooth extraction.
Moreno-Rabié C; Gaêta-Araujo H; Ferreira-Leite A; Coucke W; Gielen E; Van den Wyngaert T; Jacobs R
Oral Dis; 2024 Apr; 30(3):1632-1642. PubMed ID: 36620873
[TBL] [Abstract][Full Text] [Related]
6. A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.
Howie RN; Borke JL; Kurago Z; Daoudi A; Cray J; Zakhary IE; Brown TL; Raley JN; Tran LT; Messer R; Medani F; Elsalanty ME
PLoS One; 2015; 10(7):e0132520. PubMed ID: 26186665
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing medication-related osteonecrosis of the jaw before dental extraction.
Al-Sarraj M; Burns M; Patel V
Br Dent J; 2023 Nov; 235(10):783-788. PubMed ID: 38001199
[TBL] [Abstract][Full Text] [Related]
8. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
[TBL] [Abstract][Full Text] [Related]
9. Survey of the association between tooth extraction and development of medication-related osteonecrosis of the jaw in patients undergoing cancer treatment with bone-modifying agents.
Nozawa-Kobayashi M; Sakuma H; Kanemaru H; Kurokawa A; Soga M; Yamashita M; Niimi K; Kobayashi T
Oral Maxillofac Surg; 2024 Jun; 28(2):849-857. PubMed ID: 38296902
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HMGB1/RAGE Signaling Reduces the Incidence of Medication-Related Osteonecrosis of the Jaw (MRONJ) in Mice.
Gkouveris I; Hadaya D; Elzakra N; Soundia A; Bezouglaia O; Dry SM; Pirih F; Aghaloo T; Tetradis S
J Bone Miner Res; 2022 Sep; 37(9):1775-1786. PubMed ID: 35711109
[TBL] [Abstract][Full Text] [Related]
11. A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis.
Campisi G; Mauceri R; Bertoldo F; Fusco V; Bedogni A
Head Face Med; 2021 Jul; 17(1):25. PubMed ID: 34243807
[TBL] [Abstract][Full Text] [Related]
12. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
[TBL] [Abstract][Full Text] [Related]
13. Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment.
Moreno-Rabié C; Fontenele RC; Oliveira-Santos N; Nogueira-Reis F; Van den Wyngaert T; Jacobs R
Osteoporos Int; 2024 May; ():. PubMed ID: 38767743
[TBL] [Abstract][Full Text] [Related]
14. Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies.
Jiang A; Zhang Z; Qiu X; Guo Q
Arch Toxicol; 2024 Mar; 98(3):689-708. PubMed ID: 38155341
[TBL] [Abstract][Full Text] [Related]
15. The role of leukocyte and platelet-rich fibrin in the prevention of medication-related osteonecrosis of the jaw, in patients requiring dental extractions: an observational study.
Besi E; Pitros P
Oral Maxillofac Surg; 2024 Jun; 28(2):785-793. PubMed ID: 38182917
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effect of zoledronate and compressive force suppresses proliferation and differentiation of human gingival fibroblasts.
Hemmi T; Yusa K; Ishikawa S; Takano H; Fukuda M; Iino M
Br J Oral Maxillofac Surg; 2024 Jan; 62(1):63-70. PubMed ID: 38097403
[TBL] [Abstract][Full Text] [Related]
17. How does the clinical and tomographic appearance of MRONJ influences its treatment prognosis?
Moreno Rabie C; García-Larraín S; Contreras Diez de Medina D; Cabello-Salazar I; Fontenele RC; Van den Wyngaert T; Jacobs R
Dentomaxillofac Radiol; 2023 Nov; 52(8):20230304. PubMed ID: 37870051
[TBL] [Abstract][Full Text] [Related]
18. Risk of healing impairment following tooth extraction in patients administered with antiresorptive and non-antiresorptive polypharmacy.
Suryani IR; Shujaat S; Ivković U; Coucke W; Coropciuc R; Jacobs R
J Stomatol Oral Maxillofac Surg; 2024 Apr; 125(2):101645. PubMed ID: 37748709
[TBL] [Abstract][Full Text] [Related]
19. Clinical status of established MRONJ in oncology patients continuing bone-modifying agents.
Miles E; Arya R; Sproat C; Patel V
Br Dent J; 2024 May; 236(9):683-687. PubMed ID: 38730156
[TBL] [Abstract][Full Text] [Related]
20. Precursor Radiographic Findings in Patients With Medication-Related Osteonecrosis of the Jaw.
Kajihara R; Kondo E; Fukuda H; Sakai H; Koike T; Kurita H
J Oral Maxillofac Surg; 2024 Apr; ():. PubMed ID: 38750657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
